$ SOL 3.39 OVERSOLD!!!! This solar stock could run 200%

New Post Public Reply Private Reply Replies (0) Message Board
AAAAMHIM
$ SOL 3.39 OVERSOLD!!!! This solar stock could run 200% in 2 months. READ.
http://nysepost.com/renesola-ltd-adr-nysesol-...nels-37050

"But it looks like ReneSola (SOL) has still got more potential for appreciation. The stock has not rallied as much as the solar panel stocks such as Trina Solar (TSL), Jinko Solar (JKS) etc. The reason is that the company still gets a lot of revenue from the sale of polysilicon and wafers. The upstream segment has not seen the same price increase as solar panels in 2013, despite operating at near capacity. I think that prices of the upstream segment will start to increase as well and this should benefit ReneSola more than others.

Why ReneSola is Still a Good Bet

i) Upstream Segment should see a Price Increase

ReneSola is one of the lowest cost producers of polysilicon and solar wafers in the industry. The company has managed to substantially reduce its polysilicon cost over time and has reached a low 20 dollar range. The company is building a new 10,000 polysilicon plant which will further reduce its poly costs. There are only a few companies left in the polysilicon business, as the solar downturn has been brutal for high cost firms. Even the lowest cost poly producers such as GCL Poly are making losses. This situation is unsustainable and I expect the prices to increase, as capacity expansion has halted in the upstream segment. Some price increases in wafers have already happened and there is even a possibility that polysilicon may see a supply shortage in 2014. This will be bullish for ReneSola as it is the only top 10 Chinese solar panel supplier with an in-house polysilicon plant.

ii) Stock Price has Underperformed in recent times

I had earlier said in 2013 that it was a good time to buy Chinese solar stocks which were heavily underperforming the USA solar stocks. It turned out to be a good call as Chinese solar stocks have given fatter returns than the US ones. In fact Canadian Solar (CSIQ) has turned out to be the best performing stock in 2012. Note ReneSola, Jinko Solar and Canadian Solar were the best performing stocks in 2012. This year ReneSola has not done as well as the other two, despite showing improving fundamentals and sharp growth in shipments.

iii) Marketshare Gains

ReneSola has sharply increased its global footprint and marketshare in 2013. The company did not even play in the solar panel segment four years ago and now is one of the biggest solar panel shippers in the world. ReneSola is also the 2nd biggest supplier of solar wafers after GCL Poly having overtaken LDK Solar .

The fastest-growing module supplier of the first half of the year was ReneSola, another leading Chinese company. Compared to the first half of last year, the company's merchant shipments more than tripled in the first six months of 2013."ReneSola is sold out for 2013 and is already preselling its 2014 production," Jin noted.

Source - IHS

iv) 2014 could be Another Good Year for Solar Panels

ReneSola has become a complete solar panel company having successfully diversified into selling solar panels, inverters, mounting systems etc. It is being expected by market research agencies that 2014 will be another strong growth year for the solar industry with estimates of solar demand ranging between 40 to 50 GW. With solar companies not expanding capacity aggressively, further solar panel price increases are expected. This should benefit ReneSola which has become a major solar panel player. The company has also been more aggressive in expanding marketshare, so expect a higher than industry growth in revenues for ReneSola. The polysilicon plant should be completed and should be operating at full capacity with low costs. This will give good returns if polysilicon prices start to increase in 2014.

Valuation

"ReneSola's valuation remains far lower than the top valued solar companies such as Sunpower and Canadian Solar. I think that ReneSola will see its multiple expand to reach at least those of the top solar companies. The company's P/B is just ~1.3x which should go up substantially as the company starts making profits. I had earlier given a price target of at least $8, when the company was trading at $2. I think that the target should be revised to at least $10, given the relative valuations of other solar stocks are much higher at the current moment of time."


Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading